Osama Ahmed ASWANIA,Zhong JIANG,Trevor Charles ROCHE,Mark WHITAKER
申请号：
US16583734
公开号：
US20200121792A1
申请日:
2019.09.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A drug product comprises a dry powder inhalation device having a pharmaceutical composition present therein, said pharmaceutical composition comprising a compound which is (6α,11β,16α,17α)-6,9-difluoro-17-{[(fluoromethyl)thio]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl 2-furancarboxylate or a solvate thereof； a hygroscopic material, and a package which encompasses the dry powder inhalation device and the hygroscopic material defining an enclosed volume therein, wherein the enclosed volume exhibits a Relative Humidity of from 20% to 40%.
